Home > Healthcare > Medical Devices > Diagnostic Devices > Medical Imaging Phantoms Market

Medical Imaging Phantoms Market Trends

Report ID: GMI8854
Published Date: Apr 2024
Report Format: PDF

Download Free Sample

Medical Imaging Phantoms Market Trends

The growing prevalence of chronic diseases is a significant driver for market. These phantoms are essential tools for ensuring the accuracy and reliability of the diagnostic procedures associated with the diseases.

For instance, according to the World Health Organization (WHO), in 2024, around 50 million people worldwide have epilepsy, making it one of the most common neurological diseases globally. Nearly 80% of people with epilepsy live in low- and middle-income countries. Further, it is estimated that up to 70% of people living with epilepsy could live seizure-free if properly diagnosed and treated.
Phantoms are valuable tools for training healthcare professionals in epilepsy imaging. They provide a realistic simulation of brain structures and abnormalities associated with the disease, allowing clinicians to practice interpreting images and identifying seizure foci.
For chronic conditions such as cancer, radiotherapy is a common treatment modality. Phantoms are used to optimize treatment plans by accurately measuring radiation dose delivery to tumors while minimizing exposure to surrounding healthy tissues. This is crucial for improving treatment outcomes and reducing side effects.
Thus, phantoms optimize treatment planning and monitoring, supports research and development of new imaging technologies, ensures regulatory compliance, and ultimately improves patient outcomes, thereby escalating the growth of the market.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Medical imaging phantoms market size was USD 175.9 million in 2023 and is expected to reach over USD 270.2 million by 2032 owing to the increasing healthcare infrastructure and investments along with growing prevalence of chronic disorders worldwide.

Medical imaging phantoms industry from the x-ray phantoms segment is expected to record USD 90.9 million by 2032 due to their utilization in a wide range of medical specialties, from general radiography to specialized fields.

North America medical imaging phantoms industry expected to reach ISD 71.3 million by 2032 due to technological advancements in medical imaging and heavy investments in research and development in the region.

Gold Standard Phantoms, Ion Beam Applications SA., Kyoto Kagaku Co., Ltd., Leeds Test Objects, Mirion Technologies, Inc., PTW Freiburg GmbH, Pure Imaging Phantoms, and RSD Radiology Support Devices, are some of the major medical imaging phantoms companies worldwide.